Assuming the Role of Patient
As readers of The NemetzGroup newsletter know, we often use this space to consider progress in biopharma, new…
The “Forcing Function” of JPM
Biopharma companies need to balance many critical priorities, especially those that are pre-commercial.
Connecting in a Volatile Job Market
What is the correct metaphor for today’s biopharma job market? A roller-coaster? A crater? A dark cloud? A correction?……
A Practical Guide to Biopharma Year-End Planning
As summer winds down and vacations (sadly) come to an end, it’s a natural time to shift focus toward the close of the…
Building Credibility as a New Leader
Credibility is essential for leaders in any industry, but in the high-stakes world of pharma and biotech, it is even…
BIO and Boston: The Global Stage and HLYB
Attending a large conference, medical congress, or trade show can be both exhausting and exhilarating. The decision to…
Season of Transitions
Three notable transitions worthy of reflection at this point in time.
Medical Affairs Is Stepping Into the Future
The energy was palpable at the 2025 Medical Affairs Professional Society (MAPS) Global Annual Meeting. Conversations…
Rare Disease Day … The Power of Many Voices
Rare Disease Day unites this wide range of conditions under one shared umbrella, fostering a global community that…